Amarin Corp. Plc (AMRN)
13.70
-0.14
(-1.05%)
USD |
NASDAQ |
Sep 02, 12:42
Amarin Cash from Operations (Annual) : 6.744M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 6.744M |
| December 31, 2024 | -31.03M |
| December 31, 2023 | 6.907M |
| December 31, 2022 | -179.98M |
| December 31, 2021 | -66.53M |
| December 31, 2020 | -21.92M |
| December 31, 2019 | -9.405M |
| December 31, 2018 | -94.54M |
| December 31, 2017 | -33.19M |
| December 31, 2016 | -71.32M |
| December 31, 2015 | -83.86M |
| December 31, 2014 | -72.30M |
| December 31, 2013 | -190.71M |
| December 31, 2012 | -122.94M |
| Date | Value |
|---|---|
| December 31, 2011 | -39.61M |
| December 31, 2010 | -33.86M |
| December 31, 2009 | -28.03M |
| December 31, 2008 | -26.35M |
| December 31, 2007 | -25.01M |
| December 31, 2006 | -22.78M |
| December 31, 2005 | -14.71M |
| December 31, 2004 | -10.71M |
| December 31, 2003 | -20.50M |
| December 31, 2002 | 5.235M |
| December 31, 2001 | 16.72M |
| December 31, 2000 | 5.689M |
| December 31, 1999 | -9.534M |
| December 31, 1998 | -5.503M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Neurocrine Biosciences, Inc. | 782.70M |
| Alkermes Plc | 520.75M |
| Cellectis SA | -40.14M |
| Akari Therapeutics Plc | -10.59M |
| Liquidia Corp. | -35.69M |